What is the recommended dosage of syrup cotrimoxazole (trimethoprim/sulfamethoxazole) 40/200?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cotrimoxazole 40/200 Syrup Dosing

For pediatric treatment of infections, administer 8 mg/kg/day of trimethoprim (40 mg/kg/day sulfamethoxazole) divided into two doses every 12 hours, which translates to 1 mL per kg of body weight per dose using the 40/200 suspension. 1

Standard Treatment Dosing

The FDA-approved dosing for children over 2 months of age with urinary tract infections, acute otitis media, or shigellosis is:

  • 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, divided every 12 hours 1
  • Using the 40/200 mg/5mL suspension (8/40 mg per mL), this equals 1 mL/kg/dose given twice daily 1

Weight-Based Dosing Table

For practical administration using the 40/200 suspension 1:

  • 10 kg child: 10 mL twice daily
  • 20 kg child: 20 mL twice daily
  • 30 kg child: 30 mL twice daily (or 1.5 double-strength tablets)
  • 40 kg child: 40 mL twice daily (or 2 double-strength tablets)

Treatment Duration by Indication

  • Urinary tract infections: 10-14 days 1
  • Acute otitis media: 10 days 1
  • Shigellosis/dysentery: 5 days 1, 2
  • Pneumonia (severe): 15-20 mg/kg/day TMP divided every 6-8 hours 2

Prophylaxis Dosing

For Pneumocystis jiroveci pneumonia (PCP) prophylaxis in immunocompromised children:

  • 150 mg/m²/day trimethoprim with 750 mg/m²/day sulfamethoxazole, divided twice daily 3, 4
  • Alternative schedule: Same total daily dose given 3 consecutive days per week 4
  • The CDC recommends this three-day weekly schedule as preferred for prophylaxis 4

For simple prophylaxis of recurrent UTIs:

  • 2 mg/kg trimethoprim with 10 mg/kg sulfamethoxazole once daily 5

Critical Safety Considerations

Contraindications:

  • Do not use in infants under 2 months of age 1
  • Avoid in patients with G6PD deficiency due to hemolytic anemia risk 3
  • Avoid in pregnancy at term 3

Monitoring requirements:

  • Obtain baseline complete blood count and monitor monthly for hematologic toxicity, particularly thrombocytopenia 3, 4
  • If life-threatening toxicity occurs, permanently discontinue 4

Renal Dose Adjustment

For children with impaired renal function 2, 1:

  • CrCl 15-30 mL/min: Reduce dose by 50%
  • CrCl <15 mL/min: Reduce dose by 50% or use alternative agent
  • Hemodialysis: Give 50% dose after each dialysis session

Common Pitfalls to Avoid

The most critical error is underdosing in serious infections—the standard 8 mg/kg/day TMP is appropriate for uncomplicated infections, but severe infections like PCP require 15-20 mg/kg/day TMP divided every 6 hours 1. Research demonstrates that even double-dose cotrimoxazole (16 mg/kg/day TMP) shows equivalent efficacy to standard dosing for pneumonia without increased toxicity 6, though this is not FDA-approved.

Ensure accurate weight-based dosing rather than age-based approximations, as plasma concentrations vary significantly with improper dosing 7. Treatment failure is more likely when medication is not administered correctly 6.

Do not use concurrent methotrexate at treatment doses due to severe bone marrow suppression risk, though lower prophylactic methotrexate doses are generally tolerated 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Daily Dosing of Septrin (Trimethoprim-Sulfamethoxazole)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prophylaxis with Septran DS in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The dosage of co-trimoxazole in childhood.

European journal of clinical pharmacology, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.